← Back to Patent Explorer
US3876787A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for lowering blood pressure in mammals

Assignee: Wyeth Holdings LLC
•
Filing: 1973-08-27
•
Granted: 1975-04-08
•
Expires: 1993-08-27
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This disclosure describes a method of lowering blood pressure in mammals by the administration of compositions containing as the active component certain 6-(substituted-phenyl)-4,5-dihydro-3(2H) -pyridazinones.

Inventors

  • 👤 Francis Joseph Mcevoy
  • 👤 Jr George Rodger Allen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 21:12
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/495; A61K31/50

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 48 words
A THERAPEUTIC COMPOSITION IN DOSAGE UNIT FORM USEFUL FOR LOWERING BLOOD PRESSURE IN MAMMALS COMPRISING FROM ABOUT 50 MG. TO ABOUT 1.0 GRAM PER DAILY DOSAGE UNIT OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF 4,5-DIHYDRO-66-(PMETHYLAMINOPHENYL)-3(2H)-PYRIDAZINONE AND THE PHARMACOLOGICALLY ACCEPTABLE ACID-ADDITION SALTS THEREOF, AND A PHARMACEUTICAL CARRIER.
Claim 2
Dependent Claim 48 words
A THERAPEUTIC COMPOSITION IN DOSAGE UNIT FORM USEFUL FOR LOWERING BLOOD PRESSURE IN MAMMALS COMPRISING FROM ABOUT 50 MG. TO ABOUT 1.0 GRAM PER DAILY DOSAGE UNIT OF A COMPOUND SELECTED FROM THE GROUP CONSISTING OF 4,5-DIHYDRO-66-(PMETHYLAMINOPHENYL)-3(2H)-PYRIDAZINONE AND THE PHARMACOLOGICALLY ACCEPTABLE ACID-ADDITION SALTS THEREOF, AND A PHARMACEUTICAL CARRIER.
Claim 3
Dependent Claim 33 words
A therapeutic composition in dosage unit form useful for lowering blood pressure in mammals comprising from about 50 mg. to about 1.0 gram per daily dosage unit of N-ethyl-4''-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)acetanilide and a pharmaceutical carrier.
Claim 4
Dependent Claim 33 words
A therapeutic composition in dosage unit form useful for lowering blood pressure in mammals comprising from about 50 mg. to about 1.0 gram per daily dosage unit of N-ethyl-4''-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)acetanilide and a pharmaceutical carrier.
Claim 5
Independent Claim 64 words
The method of lowering blood pressure in a mammal which comprises administering internally to said mammal an effective amount of a compound selected from the group consisting of 4,5-dihydro-6-(p-methylaminophenyl)-3(2H)-pyridazinone and the pharmacologically acceptable acid-addition salts thereof, in association with a pharmaceutical carrier to provide a daily dosage of from about one mg. to about 15 mg. per kilogram of body weight of said mammal.
Claim 6
Independent Claim 64 words
The method of lowering blood pressure in a mammal which comprises administering internally to said mammal an effective amount of a compound selected from the group consisting of 4,5-dihydro-6-(p-methylaminophenyl)-3(2H)-pyridazinone and the pharmacologically acceptable acid-addition salts thereof, in association with a pharmaceutical carrier to provide a daily dosage of from about one mg. to about 15 mg. per kilogram of body weight of said mammal.
Claim 7
Independent Claim 50 words
The method of lowering blood pressure in a mammal which comprises administering internally to said mammal an effective amount of N-ethyl-4''-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl) acetanilide in association with a pharmaceutical carrier to provide a daily dosage of from about one mg. to about 15 mg. per kilogram of body weight of said mammal.
Claim 8
Independent Claim 50 words
The method of lowering blood pressure in a mammal which comprises administering internally to said mammal an effective amount of N-ethyl-4''-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl) acetanilide in association with a pharmaceutical carrier to provide a daily dosage of from about one mg. to about 15 mg. per kilogram of body weight of said mammal.

References Cited (Backward Citations)

US3475431A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-04-07 1978-10-07 1979-04-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-04-07 1982-10-07 1983-04-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-04-07 1986-10-07 1987-04-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag